Modulation of endogenous Smad expression in normal skin fibroblasts by transforming growth factor-β

Yasuji Mori, Shu-jen Chen, John Varga

Research output: Contribution to journalArticle

92 Citations (Scopus)

Abstract

Transforming growth factor-β (TGF-β) stimulation of collagen synthesis plays a fundamental role in physiological tissue repair as well as pathological fibrosis. Members of the SMAD family of intracellular proteins are phosphorylated by TGF-β receptors and convey signals to specific TGF-β- inducible genes. Ligand binding initiates signaling through the SMAD pathway, but it is unknown how signaling is terminated. The expression and regulation of Smads have been characterized mostly in transformed cells using transient expression systems. In this study, we investigated the physiological regulation of endogenous Smads by TGF-β in nontransformed normal skin fibroblasts in vitro. Treatment with TGF-β resulted in time and dose- dependent translocation of SMAD3 and SMAD4 from the cytoplasm to the nucleus. The levels of SMAD3 and Smad3 mRNA were profoundly down-regulated by TGF-β1 or TGF-β3 in a time-dependent manner, whereas expression of antagonistic Smad7 was rapidly and transiently induced. The stability of Smad3 mRNA transcripts was unaffected by TGF-β. Cycloheximide prevented the inhibition of Smad3, but not the induction of Smad7, mRNA expression by TGF- β1, identifying Smad7 as an immediate-early gene target of TGF-β in fibroblasts. In Smad4-deficient breast cancer cells, TGF-β failed to modulate Smad expression, suggesting that SMADs mediate their own regulation in response to ligand. These results demonstrate that TGF-β not only triggers functional activation of the SMAD signaling cascade in primary skin fibroblasts, but also simultaneously exerts potent effects on endogenous SMAD expression and intracellular trafficking. Taken together with recent reports implicating ubiquitination in SMAD turnover, these findings indicate the existence of multiple levels of control for modulating SMAD-mediated TGF-β signaling in fibroblasts.

Original languageEnglish (US)
Pages (from-to)374-383
Number of pages10
JournalExperimental Cell Research
Volume258
Issue number2
DOIs
StatePublished - Aug 1 2000

Fingerprint

Fibroblast Growth Factors
Transforming Growth Factors
Skin
Fibroblasts
Ligands
Messenger RNA
Immediate-Early Genes
Growth Factor Receptors
Ubiquitination
RNA Stability
Cycloheximide
Cytoplasm
Fibrosis
Collagen

All Science Journal Classification (ASJC) codes

  • Cell Biology

Cite this

@article{fceaba0d37494ea594b1dc57bddd3db3,
title = "Modulation of endogenous Smad expression in normal skin fibroblasts by transforming growth factor-β",
abstract = "Transforming growth factor-β (TGF-β) stimulation of collagen synthesis plays a fundamental role in physiological tissue repair as well as pathological fibrosis. Members of the SMAD family of intracellular proteins are phosphorylated by TGF-β receptors and convey signals to specific TGF-β- inducible genes. Ligand binding initiates signaling through the SMAD pathway, but it is unknown how signaling is terminated. The expression and regulation of Smads have been characterized mostly in transformed cells using transient expression systems. In this study, we investigated the physiological regulation of endogenous Smads by TGF-β in nontransformed normal skin fibroblasts in vitro. Treatment with TGF-β resulted in time and dose- dependent translocation of SMAD3 and SMAD4 from the cytoplasm to the nucleus. The levels of SMAD3 and Smad3 mRNA were profoundly down-regulated by TGF-β1 or TGF-β3 in a time-dependent manner, whereas expression of antagonistic Smad7 was rapidly and transiently induced. The stability of Smad3 mRNA transcripts was unaffected by TGF-β. Cycloheximide prevented the inhibition of Smad3, but not the induction of Smad7, mRNA expression by TGF- β1, identifying Smad7 as an immediate-early gene target of TGF-β in fibroblasts. In Smad4-deficient breast cancer cells, TGF-β failed to modulate Smad expression, suggesting that SMADs mediate their own regulation in response to ligand. These results demonstrate that TGF-β not only triggers functional activation of the SMAD signaling cascade in primary skin fibroblasts, but also simultaneously exerts potent effects on endogenous SMAD expression and intracellular trafficking. Taken together with recent reports implicating ubiquitination in SMAD turnover, these findings indicate the existence of multiple levels of control for modulating SMAD-mediated TGF-β signaling in fibroblasts.",
author = "Yasuji Mori and Shu-jen Chen and John Varga",
year = "2000",
month = "8",
day = "1",
doi = "10.1006/excr.2000.4930",
language = "English (US)",
volume = "258",
pages = "374--383",
journal = "Experimental Cell Research",
issn = "0014-4827",
publisher = "Academic Press Inc.",
number = "2",

}

Modulation of endogenous Smad expression in normal skin fibroblasts by transforming growth factor-β. / Mori, Yasuji; Chen, Shu-jen; Varga, John.

In: Experimental Cell Research, Vol. 258, No. 2, 01.08.2000, p. 374-383.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Modulation of endogenous Smad expression in normal skin fibroblasts by transforming growth factor-β

AU - Mori, Yasuji

AU - Chen, Shu-jen

AU - Varga, John

PY - 2000/8/1

Y1 - 2000/8/1

N2 - Transforming growth factor-β (TGF-β) stimulation of collagen synthesis plays a fundamental role in physiological tissue repair as well as pathological fibrosis. Members of the SMAD family of intracellular proteins are phosphorylated by TGF-β receptors and convey signals to specific TGF-β- inducible genes. Ligand binding initiates signaling through the SMAD pathway, but it is unknown how signaling is terminated. The expression and regulation of Smads have been characterized mostly in transformed cells using transient expression systems. In this study, we investigated the physiological regulation of endogenous Smads by TGF-β in nontransformed normal skin fibroblasts in vitro. Treatment with TGF-β resulted in time and dose- dependent translocation of SMAD3 and SMAD4 from the cytoplasm to the nucleus. The levels of SMAD3 and Smad3 mRNA were profoundly down-regulated by TGF-β1 or TGF-β3 in a time-dependent manner, whereas expression of antagonistic Smad7 was rapidly and transiently induced. The stability of Smad3 mRNA transcripts was unaffected by TGF-β. Cycloheximide prevented the inhibition of Smad3, but not the induction of Smad7, mRNA expression by TGF- β1, identifying Smad7 as an immediate-early gene target of TGF-β in fibroblasts. In Smad4-deficient breast cancer cells, TGF-β failed to modulate Smad expression, suggesting that SMADs mediate their own regulation in response to ligand. These results demonstrate that TGF-β not only triggers functional activation of the SMAD signaling cascade in primary skin fibroblasts, but also simultaneously exerts potent effects on endogenous SMAD expression and intracellular trafficking. Taken together with recent reports implicating ubiquitination in SMAD turnover, these findings indicate the existence of multiple levels of control for modulating SMAD-mediated TGF-β signaling in fibroblasts.

AB - Transforming growth factor-β (TGF-β) stimulation of collagen synthesis plays a fundamental role in physiological tissue repair as well as pathological fibrosis. Members of the SMAD family of intracellular proteins are phosphorylated by TGF-β receptors and convey signals to specific TGF-β- inducible genes. Ligand binding initiates signaling through the SMAD pathway, but it is unknown how signaling is terminated. The expression and regulation of Smads have been characterized mostly in transformed cells using transient expression systems. In this study, we investigated the physiological regulation of endogenous Smads by TGF-β in nontransformed normal skin fibroblasts in vitro. Treatment with TGF-β resulted in time and dose- dependent translocation of SMAD3 and SMAD4 from the cytoplasm to the nucleus. The levels of SMAD3 and Smad3 mRNA were profoundly down-regulated by TGF-β1 or TGF-β3 in a time-dependent manner, whereas expression of antagonistic Smad7 was rapidly and transiently induced. The stability of Smad3 mRNA transcripts was unaffected by TGF-β. Cycloheximide prevented the inhibition of Smad3, but not the induction of Smad7, mRNA expression by TGF- β1, identifying Smad7 as an immediate-early gene target of TGF-β in fibroblasts. In Smad4-deficient breast cancer cells, TGF-β failed to modulate Smad expression, suggesting that SMADs mediate their own regulation in response to ligand. These results demonstrate that TGF-β not only triggers functional activation of the SMAD signaling cascade in primary skin fibroblasts, but also simultaneously exerts potent effects on endogenous SMAD expression and intracellular trafficking. Taken together with recent reports implicating ubiquitination in SMAD turnover, these findings indicate the existence of multiple levels of control for modulating SMAD-mediated TGF-β signaling in fibroblasts.

UR - http://www.scopus.com/inward/record.url?scp=0034255634&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034255634&partnerID=8YFLogxK

U2 - 10.1006/excr.2000.4930

DO - 10.1006/excr.2000.4930

M3 - Article

C2 - 10896788

AN - SCOPUS:0034255634

VL - 258

SP - 374

EP - 383

JO - Experimental Cell Research

JF - Experimental Cell Research

SN - 0014-4827

IS - 2

ER -